reference/22640887

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22640887

Outgoing Links

Predicate	Object
contentType	Evaluation Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1926
issn	0959-8049
issueIdentifier	13
pageRange	1920-1926
publicationName	European journal of cancer (Oxford, England : 1990)
startingPage	1920
bibliographicCitation	D'Incalci M, Colombo T, Ubezio P, Nicoletti I, Giavazzi R, Erba E, Ferrarese L, Meco D, Riccardi R, Sessa C, Cavallini E, Jimeno J, Faircloth GT. The combination of yondelis and cisplatin is synergistic against human tumor xenografts. Eur J Cancer. 2003 Sep;39(13):1920–6. doi: 10.1016/s0959-8049(03)00490-8. PMID: 12932672.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83148ed7b44ef5d686d721efd74e6e51 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e910dd226c031dc33cdcf56b193f3bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dff175987d94dda1cc5b08278a79de2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6b9817d74091c3e704226a4aea562a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1eb123cf641bfb1fa287a6d9bf21212a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2995c1fbd55faefcb30dc9a33884826c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a44117286d907ad7973b05a5682420c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a994e1a1135e99263e4135dbba6849b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27e1105ab628a09e4d6471916de16822 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_497f2b768a9cb1fd4620e40a2c487b9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_780d1214570e39718ffa4afe147e3645 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2581f786f84ced00c9915f168ff312c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_068676b1f15fc3c5f05db2878c7afb0a
date	200309
identifier	https://doi.org/10.1016/s0959-8049%2803%2900490-8 https://pubmed.ncbi.nlm.nih.gov/12932672
isPartOf	https://portal.issn.org/resource/ISSN/0959-8049 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1697
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The combination of yondelis and cisplatin is synergistic against human tumor xenografts
discusses	http://id.nlm.nih.gov/mesh/M0011785 http://id.nlm.nih.gov/mesh/M0444141 http://id.nlm.nih.gov/mesh/M0006500 http://id.nlm.nih.gov/mesh/M0453081 http://id.nlm.nih.gov/mesh/M0004505
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010051Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D012208Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D044005 http://id.nlm.nih.gov/mesh/D004149Q000009 http://id.nlm.nih.gov/mesh/D014183 http://id.nlm.nih.gov/mesh/D002945Q000009 http://id.nlm.nih.gov/mesh/D002945Q000008 http://id.nlm.nih.gov/mesh/D009368 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D007546Q000009 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000077606 http://id.nlm.nih.gov/mesh/D007546Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004149Q000008 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D004357
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94180 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9105 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7156 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9149 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6995013 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8646 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108150 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248774860

Total number of triples: 69.